Mesenchymal stem-cell potential in cartilage repair: An update

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 12, 2014, Pages 2340-2350

  Mazor, M ^a   Lespessailles, E ^a   Coursier, R ^a,b   Daniellou, R ^a   Best, T M ^c   Toumi, H ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cartilage; Growth factors; Mesenchymal stem cell; Osteoarthritis; Repair

Indexed keywords

SCLEROPROTEIN;

ARTICULAR CARTILAGE; BIOLOGICAL MODEL; BIOLOGICAL THERAPY; CARTILAGE CELL; CHONDROGENESIS; CYTOLOGY; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; TRENDS;

CARTILAGE, ARTICULAR; CELL- AND TISSUE-BASED THERAPY; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; OSTEOARTHRITIS; REGENERATION;

EID: 84911455582     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12378     Document Type: Article

References (142)

1. Hayashi D, Guermazi A, Hunter DJ. Osteoarthritis year 2010 in review: imaging. Osteoarthritis Cartilage. 2011; 19: 354-60.
2. Mueller MB, Tuan RS. Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets. PM R. 2011; 3: S3-11.
3. Lorenz H, Richter W. Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem. 2006; 40: 135-63.
4. Khan WS, Johnson DS, Hardingham TE. The potential of stem cells in the treatment of knee cartilage defects. Knee. 2010; 17: 369-74.
5. Newman AP. Articular cartilage repair. Am J Sports Med. 1998; 26: 309-24.
6. Ishiguro N, Kojima T, Poole AR. Mechanism of cartilage destruction in osteoarthritis. Nagoya J Med Sci. 2002; 65: 73-84.
7. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000; 133: 635-46.
8. Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis. 2012; 4: 269-85.
9. Khan IM, Gilbert SJ, Singhrao SK, et al. Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. A review. Eur Cell Mater. 2008; 16: 26-39.
10. Jiang YZ, Zhang SF, Qi YY, et al. Cell transplantation for articular cartilage defects: principles of past, present, and future practice. Cell Transplant. 2011; 20: 593-607.
11. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25, 124 knee arthroscopies. Knee. 2007; 14: 177-82.
12. Wang M, Shen J, Jin H, et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci. 2011; 1240: 61-9.
13. Freyria AM, Mallein-Gerin F. Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors. Injury. 2012; 43: 259-65.
14. Becerra J, Andrades JA, Guerado E, et al. Articular cartilage: structure and regeneration. Tissue Eng Part B Rev. 2010; 16: 617-27.
15. Poole AR, Kojima T, Yasuda T, et al. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 2001; S26-33.
16. Poole CA. Articular cartilage chondrons: form, function and failure. J Anat. 1997; 191: 1-13.
17. Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005; 24: 1-12.
18. Eyre DR. Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res. 2004; 427: S118-22.
19. Dijkgraaf LC, de Bont LG, Boering G, et al. Normal cartilage structure, biochemistry, and metabolism: a review of the literature. J Oral Maxillofac Surg. 1995; 53: 924-9.
20. Hashimoto M, Nakasa T, Hikata T, et al. Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev. 2008; 28: 464-81.
21. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993; 4: 197-250.
22. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007; 213: 626-34.
23. Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009; 11: 224.
24. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010; 1192: 230-7.
25. Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol. 2008; 4: 128-35.
26. Reboul P, Pelletier JP, Tardif G, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest. 1996; 97: 2011-9.
27. Neuhold LA, Killar L, Zhao W, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest. 2001; 107: 35-44.
28. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006; 11: 529-43.
29. Lin PM, Chen CT, Torzilli PA. Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis Cartilage. 2004; 12: 485-96.
30. Imai K, Ohta S, Matsumoto T, et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol. 1997; 151: 245-56.
31. Buttner FH, Chubinskaya S, Margerie D, et al. Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum. 1997; 40: 704-9.
32. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002; 4: 157-64.
33. Roach HI, Yamada N, Cheung KS, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005; 52: 3110-24.
34. Fukui N, Miyamoto Y, Nakajima M, et al. Zonal gene expression of chondrocytes in osteoarthritic cartilage. Arthritis Rheum. 2008; 58: 3843-53.
35. Huang K, Wu LD. Aggrecanase and aggrecan degradation in osteoarthritis: a review. J Int Med Res. 2008; 36: 1149-60.
36. Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011; 112: 3507-14.
37. Glasson SS, Askew R, Sheppard B, et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 2004; 50: 2547-58.
38. Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005; 434: 644-8.
39. Song RH, Tortorella MD, Malfait AM, et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 2007; 56: 575-85.
40. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013; 21: 16-21.
41. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001; 44: 585-94.
42. Farahat MN, Yanni G, Poston R, et al. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1993; 52: 870-5.
43. Munoz-Valle JF, Oregon-Romero E, Rangel-Villalobos H, et al. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis. Clin Exp Med. 2012; 14: 61-7.
44. Pelletier JP, Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. J Rheumatol Suppl. 1989; 18: 19-27.
45. Wood DD, Ihrie EJ, Dinarello CA, et al. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum. 1983; 26: 975-83.
46. O'Byrne EM, Blancuzzi V, Wilson DE, et al. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum. 1990; 33: 1023-8.
47. Martel-Pelletier J, McCollum R, DiBattista J, et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum. 1992; 35: 530-40.
48. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 1997; 40: 1012-9.
49. Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 1996; 39: 1535-44.
50. Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol. 1999; 154: 1159-69.
51. Goldring MB, Berenbaum F. Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage. 1999; 7: 386-8.
52. Goldring MB, Suen LF, Yamin R, et al. Regulation of collagen gene expression by prostaglandins and interleukin-1beta in cultured chondrocytes and fibroblasts. Am J Ther. 1996; 3: 9-16.
53. Fukui N, Zhu Y, Maloney WJ, et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am. 2003; 85-A(Suppl 3): 59-66.
54. Chubinskaya S, Segalite D, Pikovsky D, et al. Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors. 2008; 26: 275-83.
55. Bobinac D, Spanjol J, Marinovic M, et al. Expression of bone morphogenetic proteins, cartilage-derived morphogenetic proteins and related receptors in normal and osteoarthritic human articular cartilage. Coll Antropol. 2008; 32(Suppl 2): 83-7.
56. van der Kraan PM, Blaney Davidson EN, van den Berg WB. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's? Osteoarthritis Cartilage. 2010; 18: 735-41.
57. Sitcheran R, Cogswell PC, Baldwin AS, Jr. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 2003; 17: 2368-73.
58. Schroeppel JP, Crist JD, Anderson HC, et al. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol. 2011; 26: 377-94.
59. Yang S, Kim J, Ryu JH, et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med. 2010; 16: 687-93.
60. Madry H, Luyten FP, Facchini A. Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012; 20: 407-22.
61. Longo UG, Petrillo S, Franceschetti E, et al. Stem cells and gene therapy for cartilage repair. Stem Cells Int. 2012; 2012: 168385.
62. Sowaimel LA, Parry D. Stem cells an interactive qualifying project report. Worcester Polytechnic Institute, 2008.
63. ISSCR. Stem cell facts. Research ISfSC; 2011.
64. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003; 5: 32-45.
65. Friedenstein AJ. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol Blood Transfus. 1980; 25: 19-29.
66. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3: 393-403.
67. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
68. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009; 106: 984-91.
69. Delorme B, Ringe J, Gallay N, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood. 2008; 111: 2631-5.
70. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991; 78: 55-62.
71. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9: 204.
72. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
73. Halfon S, Abramov N, Grinblat B, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011; 20: 53-66.
74. Rozemuller H, Prins HJ, Naaijkens B, et al. Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies. Stem Cells Dev. 2010; 19: 1911-21.
75. De Schauwer C, Meyer E, Van de Walle GR, et al. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. Theriogenology. 2011; 75: 1431-43.
76. Ronziere MC, Perrier E, Mallein-Gerin F, et al. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng. 2010; 20: 145-58.
77. Chang F, Ishii T, Yanai T, et al. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res. 2008; 26: 18-26.
78. Yan H, Yu C. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy. 2007; 23: 178-87.
79. Bai T, Shu J, Wang J, et al. [Experimental research on repair of rabbit articular cartilage defects with composite of autologous cell-carriers]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008; 22: 487-91.
80. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994; 76: 579-92.
81. Mrugala D, Bony C, Neves N, et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis. 2008; 67: 288-95.
82. Dorotka R, Windberger U, Macfelda K, et al. Repair of articular cartilage defects treated by microfracture and a three-dimensional collagen matrix. Biomaterials. 2005; 26: 3617-29.
83. Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002; 10: 199-206.
84. Wakitani S, Mitsuoka T, Nakamura N, et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. 2004; 13: 595-600.
85. Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med. 2007; 1: 74-9.
86. Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 2007; 15: 226-31.
87. Nejadnik H, Hui JH, Feng Choong EP, et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010; 38: 1110-6.
88. Estes BT, Diekman BO, Gimble JM, et al. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc. 2010; 5: 1294-311.
89. Hamid AA, Idrus RB, Saim AB, et al. Characterization of human adipose-derived stem cells and expression of chondrogenic genes during induction of cartilage differentiation. Clinics 2012; 67: 99-106.
90. Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2007; 327: 449-62.
91. Sakaguchi Y, Sekiya I, Yagishita K, et al. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005; 52: 2521-9.
92. Shirasawa S, Sekiya I, Sakaguchi Y, et al. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006; 97: 84-97.
93. Li WJ, Chiang H, Kuo TF, et al. Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med. 2009; 3: 1-10.
94. Tay LX, Ahmad RE, Dashtdar H, et al. Treatment outcomes of alginate-embedded allogenic mesenchymal stem cells versus autologous chondrocytes for the repair of focal articular cartilage defects in a rabbit model. Am J Sports Med. 2012; 40: 83-90.
95. Ishii I, Mizuta H, Sei A, et al. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br. 2007; 89: 693-700.
96. Danisovic L, Varga I, Polak S. Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell. 2012; 44: 69-73.
97. Thorpe SD, Buckley CT, Vinardell T, et al. The response of bone marrow-derived mesenchymal stem cells to dynamic compression following TGF-beta3 induced chondrogenic differentiation. Ann Biomed Eng. 2010; 38: 2896-909.
98. Sekiya I, Larson BL, Vuoristo JT, et al. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res. 2005; 320: 269-76.
99. Markway BD, Tan GK, Brooke G, et al. Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant. 2010; 19: 29-42.
100. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther. 2007; 9: R55.
101. Khan WS, Adesida AB, Tew SR, et al. Bone marrow-derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditions. J Orthop Res. 2010; 28: 834-40.
102. Merceron C, Vinatier C, Portron S, et al. Differential effects of hypoxia on osteochondrogenic potential of human adipose-derived stem cells. Am J Physiol Cell Physiol. 2010; 298: C355-64.
103. Murphy CL, Thoms BL, Vaghjiani RJ, et al. Hypoxia. HIF-mediated articular chondrocyte function: prospects for cartilage repair. Arthritis Res Ther. 2009; 11: 213.
104. van Osch GJ, Brittberg M, Dennis JE, et al. Cartilage repair: past and future-lessons for regenerative medicine. J Cell Mol Med. 2009; 13: 792-810.
105. Pacifici M, Golden EB, Oshima O, et al. Hypertrophic chondrocytes. The terminal stage of differentiation in the chondrogenic cell lineage? Ann N Y Acad Sci. 1990; 599: 45-57.
106. O'Sullivan J, D'Arcy S, Barry FP, et al. Mesenchymal chondroprogenitor cell origin and therapeutic potential. Stem Cell Res Ther. 2011; 2: 8.
107. Dowthwaite GP, Bishop JC, Redman SN, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004; 117: 889-97.
108. Hiraoka K, Grogan S, Olee T, et al. Mesenchymal progenitor cells in adult human articular cartilage. Biorheology. 2006; 43: 447-54.
109. Chang HX, Yang L, Li Z, et al. Age-related biological characterization of mesenchymal progenitor cells in human articular cartilage. Orthopedics. 2011; 34: e382-8.
110. McCarthy HE, Bara JJ, Brakspear K, et al. The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse. Vet J. 2012; 192: 345-51.
111. Khan IM, Bishop JC, Gilbert S, et al. Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. Osteoarthritis Cartilage. 2009; 17: 518-28.
112. Williams R, Khan IM, Richardson K, et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS ONE. 2010; 5: e13246.
113. Alsalameh S, Amin R, Gemba T, et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004; 50: 1522-32.
114. Grogan SP, Miyaki S, Asahara H, et al. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther. 2009; 11: R85.
115. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther. 2004; 6: R422-32.
116. Jenkins G, Kemintz C, Tortora G. Anatomy and physiology - from science to life. 10.1111/jcmm.12384.
117. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage. 2000; 8: 309-34.
118. Zuscik MJ, Hilton MJ, Zhang X, et al. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest. 2008; 118: 429-38.
119. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today. 2005; 75: 200-12.
120. Akiyama H, Chaboissier MC, Martin JF, et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002; 16: 2813-28.
121. Zhou G, Zheng Q, Engin F, et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA. 2006; 103: 19004-9.
122. Smits P, Li P, Mandel J, et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 2001; 1: 277-90.
123. Topol L, Chen W, Song H, et al. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem. 2009; 284: 3323-33.
124. Enomoto-Iwamoto M, Enomoto H, Komori T, et al. Participation of Cbfa1 in regulation of chondrocyte maturation. Osteoarthritis Cartilage. 2001; 9: S76-84.
125. Adams SL, Cohen AJ, Lassova L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J Cell Physiol. 2007; 213: 635-41.
126. Carlevaro MF, Cermelli S, Cancedda R, et al. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci. 2000; 113(Pt 1): 59-69.
127. Grimaud E, Heymann D, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev. 2002; 13: 241-57.
128. Fan H, Hu Y, Qin L, et al. Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair. J Biomed Mater Res A. 2006; 77: 785-94.
129. Lafont JE, Talma S, Murphy CL. Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum. 2007; 56: 3297-306.
130. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13: 4279-95.
131. Grunder T, Gaissmaier C, Fritz J, et al. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage. 2004; 12: 559-67.
132. Schnabel M, Marlovits S, Eckhoff G, et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage. 2002; 10: 62-70.
133. Chubinskaya S, Hurtig M, Rueger DC. OP-1/BMP-7 in cartilage repair. Int Orthop. 2007; 31: 773-81.
134. Kuroda R, Usas A, Kubo S, et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum. 2006; 54: 433-42.
135. An C, Cheng Y, Yuan Q, et al. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng. 2010; 38: 1647-54.
136. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001; 2: REVIEWS3005.
137. Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci. 2005; 10: 1961-76.
138. Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 2005; 16: 205-13.
139. Hellingman CA, Koevoet W, Kops N, et al. Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development. Tissue Eng Part A. 2010; 16: 545-56.
140. Davidson D, Blanc A, Filion D, et al. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem. 2005; 280: 20509-15.
141. Moore EE, Bendele AM, Thompson DL, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage. 2005; 13: 623-31.
142. Stewart AA, Byron CR, Pondenis H, et al. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res. 2007; 68: 941-5.